Home › Funds › NUANCE INVESTMENTS, LLC › SOLV

NUANCE INVESTMENTS, LLC position in SOLV

SOLVENTUM CORP · Health Care

NUANCE INVESTMENTS, LLC reported holding 271,255 shares of SOLV (SOLVENTUM CORP) in its Q3 2026 13F filing — a position valued at US$23.9M, representing 4.39% of its reported portfolio and ranking #5 among its reported holdings. NUANCE INVESTMENTS, LLC has disclosed SOLV holdings in 10 of the last 10 reported quarters, going back to Q2 2024.

Latest position (Q3 2026)271.25K sh
Reported value held$23.91M
Portfolio Weight4.39%
First reportedQ2 2024
Last changeReduce
Updated2026-11-13

Last updated: 2026-11-13 · Source: SEC EDGAR Form 13F-HR

How NUANCE INVESTMENTS, LLC's SOLV position evolved

NUANCE INVESTMENTS, LLC first disclosed a stake in SOLV in Q2 2024 at 2,190,410 shares (US$115.8M). Across 10 filings, NUANCE INVESTMENTS, LLC increased the stake 2 time(s), trimmed it 7 time(s) and left it unchanged 0 time(s). The most recent filing (Q3 2026) shows 271,255 shares valued at US$23.9M — a reduction of -93,275 shares quarter over quarter.. Notable position changes include a 48% trim in Q1 2025 (shares were roughly flat over the following quarter), a 26% increase in Q2 2025 (shares fell 4% over the following quarter), a 46% trim in Q2 2026 (shares rose 14% over the following quarter).

Quarter by quarter

QuarterSharesValueChange
Q2 2024 2.19M $115.83M New
Q3 2024 1.64M $114.30M Reduce
Q4 2024 1.36M $89.59M Reduce
Q1 2025 700.37K $53.26M Reduce
Q2 2025 883.39K $67.00M Add
Q3 2025 696.97K $50.88M Reduce
Q4 2025 642.07K $50.88M Reduce
Q1 2026 671.15K $43.83M Add
Q2 2026 364.53K $28.12M Reduce
Q3 2026 271.25K $23.91M Reduce

Dots on the line are colored by change type; missing quarters mean no position was reported.

About SOLV and 13F data

SOLV (SOLVENTUM CORP) is a Health Care company. 41 other funds we track also report a position in SOLV — the largest reported positions include Independent Franchise Partners LLP (US$1.38B), TRIAN FUND MANAGEMENT, L.P. (US$635.5M), DAVIS SELECTED ADVISERS (US$565.4M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.

Other funds holding SOLV

All SOLV fund holders →

FAQ

How long has NUANCE INVESTMENTS, LLC held SOLV?

NUANCE INVESTMENTS, LLC has disclosed SOLV holdings in 10 of the last 10 reported quarters, going back to Q2 2024.

What is NUANCE INVESTMENTS, LLC's current position in SOLV?

As of Q3 2026, NUANCE INVESTMENTS, LLC holds 271.25K shares of SOLV (SOLVENTUM CORP), valued at $23.91M, representing 4.39% of its reported portfolio and ranking #5.

Has NUANCE INVESTMENTS, LLC been buying or selling SOLV?

In the latest 13F filing (Q3 2026), NUANCE INVESTMENTS, LLC reduced its position in SOLV.

Which other funds hold SOLV?

Other major institutional holders of SOLV include Independent Franchise Partners LLP, TRIAN FUND MANAGEMENT, L.P., DAVIS SELECTED ADVISERS, among 41 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.